Artificial intelligence is taking on Alzheimer’s
MORE specific treatments for Alzheimer’s could be developed using artificial intelligence, according to researchers at University College London (UCL).
Medics have devised a new algorithm that can automatically spot different patterns of progression in patients suffering from a range of dementias, including Alzheimer’s disease.
The algorithm, Subtype and Stage Inference - or SuStaIn – uses MRI scans to show doctors what stage the disease has reached and identify whether patients will respond better to certain treatments.
Researchers said the algorithm was able to identify three separate subtypes of Alzheimer’s disease, and said this “subtyping” would be possible very early in the disease process.
“One key reason for the failure of drug trials in Alzheimer’s disease is the broad mixture of very different patients they test; a treatment with a strong effect on a particular subgroup of patients may show no overall effect on the full population, and so fail the drug trial,” said Professor Daniel Alexander at the UCL Centre for Medical Image Computing.
“This new algorithm has the unique ability to reveal groups of patients with different variants of disease.”
The researchers are now looking for ways to apply the algorithm to other diseases, including chronic obstructive pulmonary disease.
It is believed the algorithm could be used by the NHS within the next few years. The NHS was unable to confirm the report.